Sitemap
October 09, 2016 Articles
Filter by Available Specialty
- Atezolizumab prolongs OS in previously treated NSCLC
- Cardiologist to lead presidential advisory committee on global health
- Ceritinib extends PFS in pretreated patients with ALK–rearranged NSCLC
- Dabrafenib, trametinib improve 3-year OS in advanced BRAF–mutated melanoma
- First-line pembrolizumab plus chemotherapy improves response rates, PFS in advanced NSCLC
- Investigational vaccine in cattle may prevent F. necrophorum transmission in humans
- Neoadjuvant chemoradiotherapy improves survival in locally advanced esophageal squamous cell carcinoma
- Nivolumab effective in pretreated metastatic or surgically unresectable urothelial cancer
- Pembrolizumab extends survival in advanced, PD-L1–positive NSCLC
- Similar results at 2 years seen with standard vs subscapular-sparing shoulder arthroplasty
- Study launches to evaluate technology in diabetes management